1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KARDIGAN INC.
Kardigan Inc.
XNAS: KARD
Download real time
21.20 0.18 (0.86%)
New 52W Low today
120.2K
XNAS Volume

XNAS 17 Jul, 2026 12:28 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Kardigan Inc

The latest disclosure was made by Paul L. Berns in Kardigan Inc where a trade of 1,250,000 Common Stock done at an average price of $16 was reported to US exchanges on June 22, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Paul L. Berns Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 22 Jun 2026 1,250,000 15,042,035 - 16 20,000,000 Common Stock
David P. Meeker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 20,706 20,706 - 0 Common Stock
Douglas E. Giordano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 20,706 20,706 - 0 Common Stock
Kimberly J. Popovits Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 20,706 20,706 - 0 Common Stock
Paul L. Berns Director, Ten Percent Owner 17 Jun 2026 13,792,035 13,792,035 - - Common Stock
Paul L. Berns Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 20,706 20,706 - 0 Common Stock
Paul L. Berns Director, Ten Percent Owner 17 Jun 2026 5,148,587 0 - - Series A Preferred Stock
Paul L. Berns Director, Ten Percent Owner 17 Jun 2026 1,204,000 0 - - Series B Preferred Stock
Paul L. Berns Director, Ten Percent Owner 17 Jun 2026 2,306,401 0 - - Series B-1 Preferred Stock
Timothy P. Walbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 57,573 57,573 - - Stock Option (Right to Buy)
Timothy P. Walbert Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 20,706 20,706 - 0 Common Stock
John B. Moriarty Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 47,784 47,784 - 0 Common Stock
Andy Pasternak Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 79,640 79,640 - 0 Common Stock
Jay Edelberg Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2026 47,784 183,327 - 0 Common Stock
Jay Edelberg Chief Medical Officer 17 Jun 2026 61,268 0 - - Series B Preferred Stock
Jay Edelberg Chief Medical Officer 17 Jun 2026 97,587 135,543 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters